These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34783295)
21. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis. Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060 [TBL] [Abstract][Full Text] [Related]
22. PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis. Wang J; Cai S; Xiong Q; Weng D; Wang Q; Ma Z Clin Transl Oncol; 2023 May; 25(5):1402-1412. PubMed ID: 36528701 [TBL] [Abstract][Full Text] [Related]
23. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
24. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway. Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
26. Let-7 reduces the proliferation and migration of oral cancer cells via PI3K/AKT signaling pathway. Liu Y; Li K; Zhang J; Jin L; Xu H; Duan Y J Biochem Mol Toxicol; 2024 Sep; 38(9):e23834. PubMed ID: 39230185 [TBL] [Abstract][Full Text] [Related]
27. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway. Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689 [TBL] [Abstract][Full Text] [Related]
28. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Lin Q; Chen H; Zhang M; Xiong H; Jiang Q Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related]
30. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. Li L; Zhang S; Li H; Chou H BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201 [TBL] [Abstract][Full Text] [Related]
31. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway. Long J; Pi X Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943 [TBL] [Abstract][Full Text] [Related]
32. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway. Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667 [TBL] [Abstract][Full Text] [Related]
33. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway. Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582 [TBL] [Abstract][Full Text] [Related]
36. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway. Wang J; Wang S; Chen L; Tan J Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495818 [TBL] [Abstract][Full Text] [Related]
37. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related]
38. JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway. Li J; Zhang X; Liu X; Ma X; Wang Y; Liu Y Expert Rev Anticancer Ther; 2024 Oct; 24(10):1029-1040. PubMed ID: 39254227 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
40. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling. Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]